Cetuximab: all 645 studies that test it
Page 5 of 7. Open to participants first (75), then studies with results posted, then the rest; newest registration first within each.
- Safety and Efficacy Study of Neratinib and Cetuximab to Treat Patients With Quadruple Wild-Type Metastatic Colorectal CancerWithdrawnNCT01960023Phase 1/2
- Ipilimumab, Cetuximab, and Intensity-Modulated Radiation Therapy in Treating Patients With Previously Untreated Stage III-IVB Head and Neck CancerCompletedNCT01935921Phase 1
- Phase III Trial Comparing Methotrexate and Cetuximab in First-line Treatment of Recurrent and/or Metastatic Squamous Cell Head and Neck CancerCompletedNCT01884623Phase 3
- Determination of Cetuximab Versus Cisplatin Early and Late Toxicity Events in HPV+ OPSCCStatus unknownNCT01874171Phase 3
- A Phase I Study of Nilontinib and Cetuximab in Patients With Solid TumorsTerminatedNCT01871311Phase 1
- Weekly Cetuximab/RT Versus Weekly Cisplatin/RT in HPV-Associated Oropharyngeal Squamous Cell CarcinomaStatus unknownNCT01855451Phase 3
- Randomised Phase II, Cetuximab in Combination With 5FU and Cisplatin or Carboplatin Versus Cetuximab in Combination With Paclitaxel and Carboplatin for Treatment of Patients With Metastatic Squamous Cell Carcinoma of the Head and NeckStatus unknownNCT01830556Phase 2
- Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck CancerSuspendedNCT01810913Phase 2/3
- Cetuximab/FOLFIRI With or Without Oxaliplatin and FOLFOXIRI With or Without Bevacizumab in Neoadjuvant Treatment of Non-resectable Colorectal Liver MetastasesStatus unknownNCT01802645Phase 2
- Vemurafenib, Cetuximab, and Irinotecan Hydrochloride in Treating Patients With Solid Tumors That Are Metastatic or That Cannot Be Removed by SurgeryCompletedNCT01787500Phase 1
- Study of REGN1400 Alone and in Combination With Erlotinib or Cetuximab in Patients With Certain Types of CancerCompletedNCT01727869Phase 1
- Pazopanib Plus Cetuximab for Incurable Head and Neck Squamous Cell Carcinoma (HNSCC)CompletedNCT01716416Phase 1
- Chemoradiation Plus Weekly c225 Against Locoregionally Advanced Nasopharyngeal Carcinoma (NPC)CompletedNCT01712919Phase 1/2
- Biomarker Directed Treatment in Metastatic Colorectal CancerCompletedNCT01703390Phase 2
- Influence of BRAF and PIK3K Status on the Efficacy of 5-Fluorouracil/Leucovorin/Oxaliplatin (FOLFIRI) Plus Bevacizumab or Cetuximab in Patients With RAS Wild-type Metastatic Colorectal Carcinoma and < 3 Circulating Tumor Cells (CTC)CompletedNCT01640444Phase 2
- Cetuximab and Everolimus in Treating Patients With Metastatic or Recurrent Colon Cancer or Head and Neck CancerCompletedNCT01637194Phase 1
- Chemoembolisation With CPT11 Loaded DC Bead With Cetuximab and 5FU/LV in First Line in Patients With KRAS Wildtype mCRCWithdrawnNCT01631539Not applicable
- Phase I Study of Cetuximab in Combination With 5-fluoruracil, Mitomycin C and Radiotherapy in Patients With Anal Cancer Stage T2 (>4 cm) - T4 N0-3 M0 or Any T N2-3 M0CompletedNCT01621217Phase 1
- Induction Chemotherapy Followed by Concurrent Radiation With Cetuximab or Cisplatin in Locally Advanced Nasopharyngeal CancerStatus unknownNCT01614938Phase 2
- Combination Chemotherapy, Cetuximab and Radiation for Patients With Localized Gastric CancerTerminatedNCT01611506Phase 1/2
- Cetuximab in Combination With Chemotherapy for the Treatment of Metastatic Colorectal CancerStatus unknownNCT01564810Phase 4
- Skin Changes in Head and Neck Cancer During Immuno-(Chemo-) And Radiotherapy With Erbitux® (HICARE)CompletedNCT01553032Phase 4
- Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign DiseaseTerminatedNCT01552434Phase 1
- Study of CMAB009 to Treat KRAS Wild Type Metastatic Colorectal CancerCompletedNCT01550055Phase 2/3
- MLN8237 in Head and Neck CancerCompletedNCT01540682Phase 1
- Colorectal Cancer (CRC) Cetuximab Elderly FrailTerminatedNCT01522612Phase 2
- A Study of RO5479599 Alone or in Combination With Cetuximab or Erlotinib in Participants With Metastatic and/or Locally Advanced Malignant Human Epidermal Growth Factor Receptor (HER3) Expressing Solid Tumors of Epithelial Cell OriginCompletedNCT01482377Phase 1
- Treatment Selection According to Skin Reaction to CetuximabStatus unknownNCT01472653Phase 2
- Induction Chemotherapy Followed by Cetuximab and Radiation Therapy for Head and Neck CancerCompletedNCT01467115Phase 2
- Radiation Therapy and Bortezomib and Cetuximab With or Without Cisplatin to Treat Head and Neck CancerCompletedNCT01445405Phase 1
- Efficacy of Chemotherapy, Associated to Either Cetuximab or Bevacizumab, in KRAS Wild-type Metastatic Colorectal Cancer Patients With Progressive Disease After Receiving First-line Treatment With BevacizumabCompletedNCT01442649Phase 2
- A Phase II Study In Patients With Advanced Head And Neck Cancer Of Standard Chemoradiation And Add-On CetuximabCompletedNCT01435252Phase 2
- EMD 1201081 + 5-FU + Cisplatin + Cetuximab in Subjects With Recurrent / Metastatic Squamous Cell Carcinoma of the Head and NeckTerminatedNCT01360827Phase 1
- Fluorouracil, Cisplatin, Leucovorin Calcium, and Cetuximab in Treating Patients With Adenocarcinoma of the Stomach or Gastroesophageal JunctionCompletedNCT01360086Phase 2
- TLR8 Agonist VTX-2337 and Cetuximab in Treating Patients With Locally Advanced, Recurrent, or Metastatic Squamous Cell Cancer of Head and NeckCompletedNCT01334177Phase 1
- Study to Evaluate Induction Chemotherapy Using Docetaxel, Cisplatin and Fluorouracil in Concurrence With Intensity-modulated Radiotherapy for Local Recurrent Nasopharyngeal Carcinoma (NPC)CompletedNCT01326559Phase 2
- Study of Cetuximab in Combination With mFOLFOX-6 (Oxaliplatin, Leucovorin, 5-FU) to Treat Colorectal Liver Metastatic Cancer PatientsStatus unknownNCT01322178Phase 2
- Carboplatin, Paclitaxel, Cetuximab, and Erlotinib Hydrochloride in Treating Patients With Metastatic or Recurrent Head and Neck Squamous Cell CancerCompletedNCT01316757Phase 2
- FOLFIRI in Combination With Cetuximab in the First-line Treatment of Metastatic Colorectal Cancer Including a Regular Dermal Prophylaxis to Prevent Acneiforme Follicular ExanthemaStatus unknownNCT01315990Phase 4
- Study of Imprime PGG® in Combination With Cetuximab in Subjects With Recurrent or Progressive KRAS Wild Type Colorectal CancerTerminatedNCT01309126Phase 3
- Study of AUY922 and Cetuximab in Patients With KRAS Wild-Type Metastatic Colorectal CancerCompletedNCT01294826Phase 1
- Study of Skin Toxicity of Cetuximab: Find a Link Between Skin Inflammation and Tumor ResponseCompletedNCT01292356Phase 2
- AZD6244 With Cetuximab for Solid Tumors and Colorectal CancerCompletedNCT01287130Phase 1
- Simvastatin + Cetuximab/Irinotecan in K-ras Mutant Colorectal Cancer (CRC)CompletedNCT01281761Phase 2
- Study of Chemoradiotherapy Combined With Cetuximab in Nasopharyngeal CarcinomaCompletedNCT01271439Phase 2
- A Randomized Study of GEMOX With or Without Cetuximab in Locally Advanced and Metastatic BTCCompletedNCT01267344Phase 2
- Pilot Study of Cetuximab and the Hedgehog Inhibitor IPI-926 in Recurrent Head and Neck CancerCompletedNCT01255800Phase 1
- Lenalidomide and Cetuximab in Treating Patients With Advanced Colorectal Cancer or Head and Neck CancerCompletedNCT01254617Phase 1
- Phase 1 and 2 Study of PX-866 and CetuximabCompletedNCT01252628Phase 1/2
- Intra-hepatic Chemotherapy in Patient With Non-resectable Liver Metastases From CholangiocarcinomaCompletedNCT01247337Phase 2
- Super-Selective Intraarterial Cerebral Infusion of Cetuximab (Erbitux) for Treatment of Relapsed/Refractory GBM and AACompletedNCT01238237Phase 1
- Reirradiation and Erbitux in the HNSCCCompletedNCT01237483Phase 2
- Induction and Concurrent Chemoradiotherapy With Cetuximab for Patients With Locally Advanced Nasopharyngeal CarcinomaTerminatedNCT01230476Phase 2
- Erbitux Study of CPT11, Oxaliplatin, UFToral Targeted TherapyCompletedNCT01225744Phase 2
- Selumetinib and Cetuximab in Treating Patients With Refractory Solid TumorsCompletedNCT01217450Phase 1
- Cetuximab + Gemox in Biliary Tract CancerCompletedNCT01216345Phase 2
- Cetuximab Plus Radiotherapy Versus Cisplatin Plus Radiotherapy in Locally Advanced Head and Neck CancerTerminatedNCT01216020Phase 2
- Phase I Study of Cetuximab With RO4929097 in Metastatic Colorectal CancerTerminatedNCT01198535Phase 1
- Adenoid Cystic Carcinoma, Erbitux, and Particle TherapyStatus unknownNCT01192087Phase 1/2
- Cetuximab and Simvastatin in Treating Patients With Advanced or Metastatic Colorectal CancerStatus unknownNCT01190462Phase 2
- Lapatinib and Cetuximab in Patients With Solid TumorsCompletedNCT01184482Phase 1
- Lenalidomide and Cetuximab in Patients With Advanced Solid TumorsStatus unknownNCT01166035Phase 1/2
- Lenalidomide and Cetuximab in Treating Patients With Metastatic Colorectal CancerTerminatedNCT01126450Phase 1
- Radiation Therapy and Chemotherapy, With or Without Cetuximab, Followed by Surgery in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed by SurgeryCompletedNCT01107639Phase 3
- Safety and Efficacy Study of BMS-908662 Alone or in Combination With Cetuximab in Subjects With K-RAS or B-RAF Mutation Positive Advanced or Metastatic Colorectal CancerCompletedNCT01086267Phase 1/2
- Everolimus, Cetuximab and Capecitabine in Patients With Metastatic Pancreatic CancerCompletedNCT01077986Phase 1/2
- Prognostic Factors for Patients With Advanced Colorectal Cancer Treated With Cetuximab.CompletedNCT01068132Phase 2
- Neo-adjuvant Treatment in Non-Small Cell Lung Cancer (NSCLC)CompletedNCT01059188Phase 2
- Bi-weekly Cetuximab Combined With 5-fluorouracil/Leucovorin/Oxaliplatin (FOLFOX-6) in Metastatic Colorectal CancerCompletedNCT01051167Phase 2
- Effect of Radiation Therapy Plus Temozolomide Combined With Cilengitide or Cetuximab on the 1-year Overall Survival of Patients With Newly Diagnosed MGMT-promoter Unmethylated GlioblastomaTerminatedNCT01044225Phase 2
- A Randomised Trial With Irinotecan, Cetuximab and Everolimus (ICE)Compared to Capecitabine and Oxaliplatin (CapOx) for Patients With Gemcitabin Resistant Pancreatic CancerTerminatedNCT01042028Phase 1/2
- Cetuximab/Paclitaxel/Cisplatin Concurrent Chemoradiotherapy Followed by Esophagectomy for Loco-regional Esophageal CancerStatus unknownNCT01034189Phase 2
- ASA404 in Combination With Carboplatin/Paclitaxel/Cetuximab in Treating Patients With Refractory Solid TumorsWithdrawnNCT01031212Phase 1
- Trial Comparing Two Two Sequences of Therapy in Colorectal Metastatic PatientsCompletedNCT01030042Phase 3
- Chemotherapy Plus Cetuximab Followed by Surgical Resection in Patients With Locally Advanced or Recurrent Thymoma or Thymic CarcinomaActive, not recruitingNCT01025089Phase 2
- Cetuximab in Combination With Chemotherapy for Patients With Head and Neck CancerWithdrawnNCT01020864Phase 2
- Combination of Cisplatin, Cetuximab and Temsirolimus in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and NeckTerminatedNCT01015664Phase 1/2
- Induction Chemotherapy Followed by Cetuximab Plus Definitive Radiotherapy Versus Radiation Plus CisplatinStatus unknownNCT00999700Phase 3
- Carboplatin, Ixabepilone, and Cetuximab in Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Untreated With ChemotherapyWithdrawnNCT00998101Phase 2
- Study of Adding Cetuximab to Chemotherapy for the Treatment of Advanced and/or Recurrent Cervical CancerStatus unknownNCT00997009Phase 2
- A Study of Cetuximab Combined With Cisplatin or Carboplatin/Pemetrexed as First Line Treatment in Patients With Malignant Pleural Mesothelioma.CompletedNCT00996567Phase 2
- HAI Irinotecan + IV Bevacizumab, Bevacizumab & Oxaliplatin or Bevacizumab & Cetuximab in Advanced Cancers Metastatic to LiverCompletedNCT00980239Phase 1
- Capecitabine, Irinotecan Hydrochloride, Cetuximab, and Radiation Therapy in Treating Patients Undergoing Surgery for Locally Advanced Rectal CancerCompletedNCT00972881Phase 1/2
- Treatment of Patients With Advanced Rectum Cancer With Capecitabine and Oxaliplatin Before, Under and After Radiation and With Adding Cetuximab to K-RAS Wild-type PatientsStatus unknownNCT00964457Phase 2
- Radiation Therapy and Cisplatin With or Without Cetuximab in Treating Patients With Stage IB, Stage II, or Stage IIIB Cervical CancerCompletedNCT00957411Phase 2
- Radiation Therapy, Cisplatin, Fluorouracil, and Cetuximab in Treating Patients With Locally Advanced Anal CancerTerminatedNCT00955240Phase 2
- Study of Capecitabine and Cetuximab as First-Line Therapy in Patients With Metastatic Wild Type Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Colorectal CancerWithdrawnNCT00954876Phase 2
- Hepatic Arterial Infusion Oxaliplatin + 5FU, Leucovorin, and Bevacizumab +/- CetuximabCompletedNCT00941499Phase 1
- Sirolimus and Cetuximab in Advanced MalignanciesCompletedNCT00940381Phase 1
- Image Guided Intensity Modulated Reirradiation (IG-IMRT) With Cetuximab for Locoregionally Confined Recurrent Head and Neck Squamous Cell CarcinomaWithdrawnNCT00934518Phase 2
- A Study of Neoadjuvant Bio-C/T Followed by Concurrent Bio-R/T in High-risk Locally Advanced Oral Squamous Cell CarcinomaCompletedNCT00933387Phase 2
- A Study of EZN-2208 Administered With or Without Cetuximab in Patients With Metastatic Colorectal CarcinomaStatus unknownNCT00931840Phase 2
- Boron Neutron Capture Therapy (BNCT) Combined With Cetuximab in the Treatment of Locally Recurred Head and Neck CancerTerminatedNCT00927147Phase 1/2
- Cetuximab and Trastuzumab in Treating Patients With Metastatic Pancreatic Cancer That Progressed After Previous Treatment With GemcitabineCompletedNCT00923299Phase 1/2
- Combination Study of BMS-754807 and Erbitux® in Subjects With Advanced or Metastatic Solid TumorsTerminatedNCT00908024Phase 1/2
- Sunitinib, Cetuximab, and Radiation Therapy in Treating Patients With Locally Advanced or Recurrent Squamous Cell Carcinoma of the Head and NeckTerminatedNCT00906360Phase 1
- Erlotinib in Combination With CetuximabCompletedNCT00895362Phase 1
- Paclitaxel/Carboplatin With or Without Cetuximab in CUPStatus unknownNCT00894569Phase 2
- Study Using Pharmacogenetics to Select Treatment for Head and Neck CancerWithdrawnNCT00881114Phase 2
- Chemotherapy, Radiation Therapy, and Cetuximab in Treating Patients With the Head and Neck CancerCompletedNCT00875849Phase 2